Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Here are some of the most crucial health benefits: 1
Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism
Overall, autonomic imbalances caused by obesity may be associated with the first occurrence of ferroptosis in the vagus nerve, which impairs its ability to transmit information collected by the sensory nerve to the nerve center, as well as its ability to mobilize GSH and NO to prevent ferroptosis
True enzymatic rates were obtained by subtracting the non-enzymatic rates (no enzyme present) from the total rates given by these experiments
The exact schedule should be determined by a healthcare provider based on the patients response to treatment
All patients performed the number connection test A and B using neuropsychological tests 21
